Sara
Zalba Oteiza
Colaboradora de Investigación
María Jesús
Garrido Cid
Catedrática de Universidad
María Jesús Garrido Cid-rekin lankidetzan egindako argitalpenak (20)
2024
-
Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice
Acta Pharmacologica Sinica
-
Lipid-based nanosystems: the next generation of cancer immune therapy
Journal of Hematology and Oncology, Vol. 17, Núm. 1
2023
-
Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling
Clinical Pharmacology and Therapeutics, Vol. 114, Núm. 3, pp. 623-632
2022
-
Stealth nanoparticles in oncology: Facing the PEG dilemma
Journal of Controlled Release, Vol. 351, pp. 22-36
2021
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1
-
Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration
Frontiers in Pharmacology, Vol. 12
-
Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1
British Journal of Cancer, Vol. 124, Núm. 7, pp. 1275-1285
-
Semi-mechanistic model for the antitumor response of a combination cocktail of immuno-modulators in non-inflamed (Cold) tumors
Cancers, Vol. 13, Núm. 20
2020
-
Quantification of pharmacokinetic profiles of pd-1/pd-l1 antibodies by validated elisas
Pharmaceutics, Vol. 12, Núm. 6, pp. 1-16
2019
-
A new immune-nanoplatform for promoting adaptive antitumor immune response
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 13-25
2018
-
Immunoliposomes in clinical oncology: State of the art and future perspectives
Journal of Controlled Release, Vol. 275, pp. 162-176
2016
-
EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model
Nanomedicine, Vol. 11, Núm. 5, pp. 465-477
2015
-
Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer
Journal of Controlled Release, Vol. 210, pp. 26-38
2013
-
Efficient serum-resistant lipopolyplexes targeted to the folate receptor
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 358-363
-
Liposomes, a promising strategy for clinical application of platinum derivatives
Expert Opinion on Drug Delivery, Vol. 10, Núm. 6, pp. 829-844
2012
-
Application of different methods to formulate PEG-liposomes of oxaliplatin: Evaluation in vitro and in vivo
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 81, Núm. 2, pp. 273-280
2011
-
Efficient gene delivery by EGF-lipoplexes in vitro and in vivo
Nanomedicine, Vol. 6, Núm. 1, pp. 89-98
2010
-
Application of non-aggressive sample preparation and electrothermal atomic absorption spectrometry to quantify platinum in biological matrices after cisplatin nanoparticle administration
Microchemical Journal, Vol. 96, Núm. 2, pp. 415-421
-
Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 74, Núm. 2, pp. 265-274
2009
-
Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin
European Journal of Pharmaceutical Sciences, Vol. 37, Núm. 3-4, pp. 341-350